Lv3
266 积分 2025-11-16 加入
Postoperative ctDNA in indicating the recurrence risk and monitoring the effect of adjuvant therapy in surgical non–small cell lung cancers
2个月前
已完结
Circulating tumor DNA as markers of dynamic recurrence risk and adjuvant chemotherapy benefit in resected non-small cell lung cancer
2个月前
已关闭
Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study)
2个月前
已完结
The efficacy of acupuncture in the treatment of chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis
3个月前
已完结
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
3个月前
已完结
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
3个月前
已完结
Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients
3个月前
已完结
The comings and goings of cell-free DNA: Biological and clinical implications
4个月前
已完结
Liquid biopsies across the cancer care continuum
6个月前
已完结
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma
7个月前
已完结
皖公网安备34019202002308
